Karolinska Development’s Portfolio Company Aprea Therapeutics Secures Funding Of Usd 5.5 Million
Feb 28, 2023•over 2 years ago
Description
STOCKHOLM, SWEDEN, February 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has closed an underwritten public offering of USD 5.5 million before deducting underwriting discounts, commissions, and offering expenses.
FundzWatch™ Score
61
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood